Journal of Pediatric Health Care
Volume 22, Issue 5 , Pages 282-288 , September 2008

Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil

References 

  1. Al Salloum AA. Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children. Pediatric Nephrology. 2003;18:357–361
  2. Bakkaloglu A. Lupus nephropathy in children. Nephrology Dialysis Transplantation. 2001;16(suppl 6):126–128
  3. Bansal VK, Beto JA. Treatment of lupus nephritis: A meta-analysis of clinical trials. American Journal of Kidney Diseases. 1997;29:193–199
  4. Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, et al. Childhood-onset lupus nephritis: A single-center experience of pulse intravenous cyclophosphamide therapy. Journal of Nephrology. 2002;15:123–129
  5. Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, et al. Lupus nephritis in childhood: A review of 53 patients followed at a single center. Pediatric Nephrology. 2004;19:36–44
  6. Briggs WA, Choi MJ, Scheel PJ. Successful mycophenolate mofetil treatment of glomerular disease. American Journal of Kidney Diseases. 1998;31:213–217
  7. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. Journal of Rheumatology. 2001;28:2103–2108
  8. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. New England Journal of Medicine. 2000;343:1156–1162
  9. Chan TM, Tse KC, Tang CS, Mok MY, Li FK Hong Kong Nephrology Study Group. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. Journal of American Society of Nephrology. 2005;16:1076–1084
  10. Fu YF, Liu GL. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclophosphamide and cyclosporine. Clinical Nephrology. 2001;55:318–321
  11. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. New England Journal of Medicine. 2005;353:2219–2228
  12. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C. Long-term follow up of childhood lupus nephritis. Journal of Rheumatology. 2002;29:2635–2642
  13. Hu W, Liu Z, Chen H, Tang Z, Wang Q, Shen K, et al. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chinese Medical Journal (Engl). 2002;115:705–709
  14. Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long-term follow up of a cohort of 145 patients participating in randomized controlled studies. Arthritis and Rheumatism. 2002;46:995–1002
  15. Lau KK, Jones DP, Hastings MC, Gaber LW, Ault BH. Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children. Pediatric Nephrology. 2006;21:655–662
  16. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents . Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics. 1996;98(4 Pt 1):649–658
  17. Niaudet P. Treatment of lupus nephritis in children. Pediatric Nephrology. 2000;14:158–166
  18. Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, et al. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton). 2005;10:504–510
  19. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. 1964. Journal of American Society of Nephrology. 1997;8:1189–1198
  20. Schwartz GL, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259–263
  21. Vyas S, Hidalgo G, Baqi N, Von Gizyki H, Singh A. Outcome in African-American children of neuropsychiatric lupus and lupus nephritis. Pediatric Nephrology. 2002;17:45–49
  22. Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of the renal outcome of pediatric lupus nephritis. Clinical Rheumatology. 2004;23:318–323

 Note: Figure 1 is available in color online at www.jpedhc.org.

PII: S0891-5245(07)00272-6

doi: 10.1016/j.pedhc.2007.07.006

Journal of Pediatric Health Care
Volume 22, Issue 5 , Pages 282-288 , September 2008